Manish Dixit
Pediatrics · Parsons, KSNPI 1619964418
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 242 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Supernus Pharmaceuticals, Inc. at 42.1% of the total. 2025 is the largest year on record at $1,228, more than ten times the $68 reported in 2019. Among pediatrics clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 242 payments — averaging $13.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$1K
- Corium, LLC$937
- Takeda Pharmaceuticals U.S.A., Inc.$244
- Tris Pharma Inc$166
- Ironshore Pharmaceuticals Inc.$163
- Collegium Pharmaceutical, Inc.$92
- plus $258 from 8 others
What the payments were for
- Food & beverage$3,216100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 105 | $1,355 |
| Corium, LLC | 81 | $937 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $244 |
| Tris Pharma Inc | 9 | $166 |
| Ironshore Pharmaceuticals Inc. | 15 | $163 |
| Collegium Pharmaceutical, Inc. | 5 | $92 |
| Merck | 4 | $82 |
| Sanofi Pasteur Inc. | 3 | $59 |
| Novo Nordisk | 1 | $29 |
| Irhythm Technologies, Inc. | 1 | $20 |
| Seqirus USA Inc | 1 | $19 |
| Biogen | 1 | $18 |
| Shire North American Group Inc | 1 | $17 |
| Phadia US Inc. | 1 | $14 |
How this compares
$3,216 in reported general payments places this provider in the 95th percentile of 314 pediatrics providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 12 | $1,762 |
| SprintecNorgestimate-Ethinyl Estradiol | 18 | $125 |
| Gabapentin | 11 | $88 |
| Clonazepam | 13 | $77 |
| Fluoxetine Hcl | 17 | $68 |
| Potassium Chloride | 11 | $39 |
| Amiodarone Hcl | 12 | $34 |
| Famotidine | 14 | $22 |
| ClopidogrelClopidogrel Bisulfate | 13 | $21 |
| Alendronate Sodium | 13 | $11 |
| Losartan Potassium | 13 | $10 |
Paid to pharmacies, not to this prescriber.
Other pediatrics in Parsons
- Kathleen CainTopeka$1.2M
- Wendy HeinKansas City$426K
- Matthew LindquistPrairie Village$84K
- Monica DavisWichita$17K
- Dwight LindholmWichita$9K
- Jennifer GannonOverland Park$6K
- Michael LewisKansas City$6K
- Roger UnruhWichita$5K
- Gretchen BlackKansas City$5K
- Anna SlatteryKansas City$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.